Retrospective cohort study on the safety and efficacy of docetaxel in Japanese non‐small cell lung cancer patients with nondialysis chronic kidney disease stage 3b or higher

BACKGROUND: It has been reported that 20% of lung cancer patients have renal impairment caused by chronic kidney disease (CKD). Since docetaxel is predominantly excreted by the hepatobiliary system, it is administered to non‐small cell lung cancer (NSCLC) patients with renal impairment. However, few...

Descripción completa

Detalles Bibliográficos
Autores principales: Anai, Satoshi, Ibusuki, Ritsu, Takao, Tomoaki, Sakurai, Yuko, Hisasue, Junko, Takaki, Yoichi, Hara, Naohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885428/
https://www.ncbi.nlm.nih.gov/pubmed/31631526
http://dx.doi.org/10.1111/1759-7714.13222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885428/
https://www.ncbi.nlm.nih.gov/pubmed/31631526
http://dx.doi.org/10.1111/1759-7714.13222

Ejemplares similares